211 related articles for article (PubMed ID: 26028048)
1. Tuning T Cell Activation: The Function of CD6 At the Immunological Synapse and in T Cell Responses.
Santos RF; Oliveira L; Carmo AM
Curr Drug Targets; 2016; 17(6):630-9. PubMed ID: 26028048
[TBL] [Abstract][Full Text] [Related]
2. CD6 as a Cell Surface Receptor and As a Target for Regulating Immune Responses.
Brown MH
Curr Drug Targets; 2016; 17(6):619-29. PubMed ID: 26302795
[TBL] [Abstract][Full Text] [Related]
3. CD6, a Rheostat-Type Signalosome That Tunes T Cell Activation.
Gonçalves CM; Henriques SN; Santos RF; Carmo AM
Front Immunol; 2018; 9():2994. PubMed ID: 30619347
[TBL] [Abstract][Full Text] [Related]
4. T cell activation regulates CD6 alternative splicing by transcription dynamics and SRSF1.
da Glória VG; Martins de Araújo M; Mafalda Santos A; Leal R; de Almeida SF; Carmo AM; Moreira A
J Immunol; 2014 Jul; 193(1):391-9. PubMed ID: 24890719
[TBL] [Abstract][Full Text] [Related]
5. Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapse.
Castro MA; Oliveira MI; Nunes RJ; Fabre S; Barbosa R; Peixoto A; Brown MH; Parnes JR; Bismuth G; Moreira A; Rocha B; Carmo AM
J Immunol; 2007 Apr; 178(7):4351-61. PubMed ID: 17371992
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein kinase pathway activation by the CD6 lymphocyte surface receptor.
Ibáñez A; Sarrias MR; Farnós M; Gimferrer I; Serra-Pagès C; Vives J; Lozano F
J Immunol; 2006 Jul; 177(2):1152-9. PubMed ID: 16818773
[TBL] [Abstract][Full Text] [Related]
7. The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations.
Kofler DM; Farkas A; von Bergwelt-Baildon M; Hafler DA
Curr Drug Targets; 2016; 17(6):651-65. PubMed ID: 26844569
[TBL] [Abstract][Full Text] [Related]
8. Biophysical Characterization of CD6-TCR/CD3 Interplay in T Cells.
Meddens MBM; Mennens SFB; Celikkol FB; Te Riet J; Kanger JS; Joosten B; Witsenburg JJ; Brock R; Figdor CG; Cambi A
Front Immunol; 2018; 9():2333. PubMed ID: 30356797
[TBL] [Abstract][Full Text] [Related]
9. CD6 as a therapeutic target in autoimmune diseases: successes and challenges.
Pinto M; Carmo AM
BioDrugs; 2013 Jun; 27(3):191-202. PubMed ID: 23568178
[TBL] [Abstract][Full Text] [Related]
10. The lymphocyte receptor CD6 interacts with syntenin-1, a scaffolding protein containing PDZ domains.
Gimferrer I; Ibáñez A; Farnós M; Sarrias MR; Fenutría R; Roselló S; Zimmermann P; David G; Vives J; Serra-Pagès C; Lozano F
J Immunol; 2005 Aug; 175(3):1406-14. PubMed ID: 16034076
[TBL] [Abstract][Full Text] [Related]
11. Targeting CD6 for the treatment of experimental autoimmune uveitis.
Zhang L; Li Y; Qiu W; Bell BA; Dvorina N; Baldwin WM; Singer N; Kern T; Caspi RR; Fox DA; Lin F
J Autoimmun; 2018 Jun; 90():84-93. PubMed ID: 29472120
[TBL] [Abstract][Full Text] [Related]
12. CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.
Nair P; Melarkode R; Rajkumar D; Montero E
Clin Exp Immunol; 2010 Oct; 162(1):116-30. PubMed ID: 20726988
[TBL] [Abstract][Full Text] [Related]
13. Activation of human T cells through CD6: functional effects of a novel anti-CD6 monoclonal antibody and definition of four epitopes of the CD6 glycoprotein.
Bott CM; Doshi JB; Morimoto C; Romain PL; Fox DA
Int Immunol; 1993 Jul; 5(7):783-92. PubMed ID: 7690243
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Targeting of CD6 in Autoimmune Diseases: A Review of Cuban Clinical Studies with the Antibodies IOR-T1 and Itolizumab.
Hernández P; Moreno E; Aira LE; Rodríguez PC
Curr Drug Targets; 2016; 17(6):666-77. PubMed ID: 26844560
[TBL] [Abstract][Full Text] [Related]
15. Human CD6 possesses a large, alternatively spliced cytoplasmic domain.
Robinson WH; Neuman de Vegvar HE; Prohaska SS; Rhee JW; Parnes JR
Eur J Immunol; 1995 Oct; 25(10):2765-9. PubMed ID: 7589069
[TBL] [Abstract][Full Text] [Related]
16. Compromised levels of CD6 and reduced T cell activation in the aged immune system.
Kureel AK; Saini S; Singh B; Singh K; Rai AK
Biomarkers; 2021 Jul; 26(5):483-490. PubMed ID: 33913383
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of CD6 expression on human T lymphocytes by phorbol ester.
Bott CM; Doshi JB; Li LL; McMurtry SA; Sanders JL; Fox DA
J Immunol; 1994 Jul; 153(1):1-9. PubMed ID: 8207228
[TBL] [Abstract][Full Text] [Related]
18. CD6-mediated inhibition of T cell activation via modulation of Ras.
Henriques SN; Oliveira L; Santos RF; Carmo AM
Cell Commun Signal; 2022 Nov; 20(1):184. PubMed ID: 36414966
[TBL] [Abstract][Full Text] [Related]
19. The anti-CD6 mAb, IOR-T1, defined a new epitope on the human CD6 molecule that induces greater responsiveness in T cell receptor/CD3-mediated T cell proliferation.
Osorio LM; Garcia CA; Jondal M; Chow SC
Cell Immunol; 1994 Mar; 154(1):123-33. PubMed ID: 7509726
[TBL] [Abstract][Full Text] [Related]
20. CD6 modulates thymocyte selection and peripheral T cell homeostasis.
Orta-Mascaró M; Consuegra-Fernández M; Carreras E; Roncagalli R; Carreras-Sureda A; Alvarez P; Girard L; Simões I; Martínez-Florensa M; Aranda F; Merino R; Martínez VG; Vicente R; Merino J; Sarukhan A; Malissen M; Malissen B; Lozano F
J Exp Med; 2016 Jul; 213(8):1387-97. PubMed ID: 27377588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
